@misc{7e3023353658496ea4a710872bcda4d7,
title = "Compounds and anti-tumor NQO1 substrates",
abstract = "Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.",
author = "Bair, {Joseph S} and Rahul Palchaudhuri and Boothman, {David A} and Hergenrother, {Paul J} and Parkinson, {Elizabeth I}",
note = "GOVERNMENT SUPPORT This invention was made with government support under contract number CA102792 awarded by the National Institutes of Health. The government has certain rights in the invention. RELATED APPLICATIONS This application is a national stage filing under 35 U.S.C. §371 of PCT/US2012/059988, filed Oct. 12, 2012, which claims priority to U.S. Provisional Patent Application Nos. 61/547,166 filed Oct. 14, 2011 and 61/662,163 filed Jun. 20, 2012, which applications are incorporated herein by reference in their entireties.; 9233960",
year = "2016",
month = jan,
day = "12",
language = "English (US)",
type = "Patent",
}